The extracellular matrix glycoprotein, fibronectin, influences a variety of cellular functions including adhesion, migration, survival, differentiation, and growth. Fibronectin has also been shown to increase the migration and proliferation of human lung carcinoma cells. However, the role of fibronectin in controlling lung airway epithelial cell phenotype remains unknown. Here, we demonstrate that fibronectin stimulates the proliferation of human bronchial epithelial cells (BEAS-2B and 16-HBE). Of note, fibronectin induced the mRNA and protein expression of c-Myc and cyclin D1, while it decreased the expressions of cyclin-dependent kinase inhibitor p21
Introduction
The extracellular matrix influences a variety of cellular functions including adhesion, migration, survival, and differentiation. Fibronectin, a matrix glycoprotein highly expressed in tobacco-related lung diseases, has been shown to influence cell growth and differentiation through effects on genes such as p53, c-Myc, cyclin D1, cyclin-dependent kinase inhibitor p21 WAF-1/CIP1/MDA-6 (p21), and phosphatase and tensin homolog deleted on chromosome ten (PTEN), among others (Tamura et al., 1998; Danen et al., 2000; Zhang et al., 2003) . c-Myc is an oncogenic transcription factor involved in the control of cell proliferation, differentiation, and apoptosis. In vitro studies have demonstrated that c-Myc is required for the proliferation of many cell types, and that it promotes cell cycle progression by upregulating the activity of proteins controlling key events in G 1 phase, such as cyclin D2, E2F, cyclin E, and cyclin-dependent kinase 4, while downregulating the levels or activity of p21
Waf1 and p27
Kip1 (Amati et al., 1998; Rajabi et al., 2005) . Here, we explore the effects of fibronectin on these processes in human bronchial epithelial cells.
Human airway epithelial cells synthesize matrix components that provide key survival signals, and these general mechanisms have been shown to operate in a model cell line (BEAS-2B) as well as in cultured primary bronchial epithelial cells (Wadsworth et al., 2004) . Among these matrix components is fibronectin. We previously demonstrated that fibronectin stimulates human non-small-cell lung carcinoma cell growth through upregulation of cyclooxygenase-2 (COX-2) and cyclin D1, and by reducing p21 gene expression (Han et al., 2004 (Han et al., , 2005 . These activities of fibronectin occurred in a Rho-dependent fashion and may explain its potent role in the stimulation of cell cycle progression in tumor cells (Danen et al., 2000) . However, studies evaluating the effect of fibronectin on non-transformed epithelial cells such as human bronchial epithelial cells, with special attention to proliferation, are scarce. Herein, we explore the effects of fibronectin on human bronchial epithelial cell proliferation and the intracellular signals involved in this process. We found that fibronectin stimulates human bronchial epithelial cell proliferation through activation of nuclear factor kappaB (NF-kB), which, in turn, increases the expression of c-Myc and cyclin D1, and decreases the expression of p21 and PTEN via a5b1-dependent signals that include phosphatidylinositol 3-kinase (PI3-K)/Akt.
Results

Induction of cell growth and inhibition of apoptosis in human bronchial epithelial cells by fibronectin
Fibronectin has been shown to stimulate normal cell and tumor cell proliferation (de Jong-Hesse et al., 2005; Illario et al., 2005) . To examine the effects of fibronectin on human bronchial epithelial cell proliferation, cells were treated with increased concentrations of fibronectin and incubated with 1 mCi/ml [methyl- 3 H]thymidine for 24 h. As shown in Figure 1a , fibronectin stimulated the proliferation of two human bronchial epithelial cell lines when cells were cultured on fibronectin-coated plates for up to 24 h as determined by [
3 H]thymidine incorporation assay with a maximal induction at 20 mg/ml fibronectin concentration. In parallel experiments, we showed that fibronectin reduced cell apoptosis as reflected by a decrease in DNA fragmentation (lane 2) noted at 48 h as compared to the untreated control cells (lane 1) (Figure 1b) , and this was further confirmed by showing that fibronectin (20 mg/ml) decreased caspase-3/7 activities when tested under the same conditions (Figure 1c) . Similar results were observed in 16-HBE cells (data not shown).
Fibronectin affects the expression of c-Myc, cyclin D1, p21, and PTEN Fibronectin has been shown to affect the expression of certain genes including p21, cyclin D1 and PTEN (Tamura et al., 1998; Danen et al., 2000; Zhang et al., 2003) . We therefore tested whether the induction of bronchial epithelial cell growth by fibronectin involves differential expression of these genes. As shown in Figure 2a and b, BEA-2B cells exposed to fibronectin showed increased expression of c-Myc, an oncogenic transcription factor, and cyclin D1, a G-phase control protein. In the same cells, fibronectin decreased the expression of the cyclindependent kinase inhibitor p21, and the tumor suppressor gene, PTEN. These effects occurred in a dose (a)-and time-dependent manner (b) with optimal dose of fibronectin of 20 mg/ml at 24 h. Consistent with these findings related to protein expression, fibronectin also affected the expression of mRNAs encoding for these genes as determined by real-time RT-PCR analysis shown in Figure 2c .
The role of PI3-K and a5b1 integrin signals in mediating the effects of fibronectin Several kinase signal pathways including PI3-K have been demonstrated to mediate the cellular effects of fibronectin (Kijima et al., 2003; Liu et al., 2004) . We therefore tested if this was also the case for human bronchial epithelial cells. As shown in Figure 3a , fibronectin induced the phosphorylation of the PI3-K downstream signal, Akt, starting at 30 min, while it had no effect on total Akt and protein kinase C (PKC) levels. Moreover, the inhibitor of PI3-K, Wortmannin, was found to block the effect of fibronectin on the expression of c-Myc, cyclin D1, p21, and PTEN ( Figure 3b ). This suggests that activation of the PI3-K signal pathway is necessary for fibronectin-induced regulation of these genes.
Many of the biological effects of fibronectin are mediated via the integrin receptor a5b1, we next examined if blocking activation of this integrin could eliminate the effects of fibronectin. As shown in Figure 3c , the effects of fibronectin on p21, cyclin D1, The electrophoretic pattern of the DNA ladder was determined by running the DNA on a 1.5% agarose gel in 1 Â TAE followed by ethidium bromide staining. (c) Effects on caspase 3/7 activity. BEAS-2B cells were cultured in 96-well plates in the presence or absence of fibronectin (20 mg/ml) for 48 h. Afterwards, caspase-3/7 activities were measured using the caspase-3/7 assay kit (Promega).
Fibronectin induces human bronchial epithelial cell growth SW Han and J Roman PTEN, and c-Myc protein levels were blocked in the presence of an anti-a5b1 antibody (MAB1969), while the anti-a2b1 antibody (MAB1967) had no effect. This suggests that effects of fibronectin were dependent on a5b1 integrin activation.
Fibronectin increases NF-kB binding to DNA and p65 protein expression The NF-kB family of transcription factors is ubiquitous in carcinogenesis. Since NF-kB-associated pathways are linked to cell proliferation, invasion, and angiogenesis as well (Wu and Kral, 2005) , we explored the effect of fibronectin on NF-kB DNA-binding activity in BEA-2B cells. As shown in Figure 4a , fibronectin increased the DNA-binding activity of NF-kB. Addition of an anti-p65 antibody resulted in a supershift of this binding complex in the presence of fibronectin. We also found that fibronectin increased the expression of p65 protein in a dose-and timedependent fashion with maximal induction at 20 mg/ml in 24 h (Figure 4b and c). To test if the PI3-K signal is upstream of the effect of fibronectin on p65 expression, cells were exposed to the PI3-K inhibitor, Wortmannin. These studies showed that Wortmannin blocks the stimulatory effect of fibronectin on p65 protein expression indicating that PI3-K is an upstream signal of NF-kB ( Figure 4d ).
p65 small interfering RNA (siRNA) blocks the effects of fibronectin on protein expression and cell proliferation To determine the role of NF-kB in mediating the effects of fibronectin on PI3-K signals, protein expression, and cell proliferation, we examined whether blockade of the NF-kB signal could abolish the effects of fibronectin using siRNA methods. We first tested the efficiency of the p65 siRNA. As shown in Figure 5a , BEAS-2B cells transfected with p65 siRNA showed inhibition of p65 protein expression, while the control siRNA had no effect. We found that blockade of NF-kB signal by p65 siRNA did not inhibit the effect of fibronectin on phosphorylation of Akt suggesting that PI3-K acts upstream of NF-kB ( Figure 5b ). However, the p65 siRNA blocked the effects of fibronectin on upregulation of c-Myc and cyclin D, and that of downregulation of p21 and PTEN protein expression ( Figure 5c ). Also, the p65 siRNA abrogated the stimulatory effect of fibronectin on BEAS-2B cell proliferation; the effect of fibronectin on cell growth was completely abolished in the presence of both p65 siRNA and Wortmannin ( Figure 5d ). These observations suggested that NF-kB signals were involved in the control of gene expression, and human bronchial epithelial cell growth is affected by fibronectin. W o r t m a n n in F n + W o r t m a n n in C o n F n W o r t m a n n in F n + W o r t m a n n in (c) Effects of a5b1 integrin inhibition on p21, cyclin D1, PTEN, and c-Myc protein expression. Cellular protein was isolated from BEAS-2B cells cultured for 2 h in the presence or absence of anti-a5b1 integrin antibody (MAB1969), or anti-a2b1 integrin antibody (MAB1967) (25 mg/ml each) before exposing the cells to fibronectin (20 mg/ml) for an additional 24 h, then subjected to Western Blot analysis for p21, cyclin D1, PTEN, and c-Myc. Densitometry analysis of the p21, cyclin D1, PTEN, and c-Myc /actin band is shown in lower panel. Actin served as internal control for normalization purposes. *Indicates significant differences as compared to the vehicle control (Con). **Indicates significance of combination treatment as compared with fibronectin alone. Con, indicates untreated cells.
Fibronectin induces human bronchial epithelial cell growth SW Han and J Roman extracellular matrix glycoprotein fibronectin on the expression of those types of genes in human bronchial epithelial cells, and to study how this influenced cell growth and apoptosis. Fibronectin has been shown to increase the survival of human lung fibroblasts and bronchial epithelial cells (Aoshiba et al., 1997; Cordes and Beinke, 2004) ; however, the cellular mechanisms responsible for this effect remain unknown. Similarly, fibronectin is also capable of modulating the apoptosis of bronchial epithelial cells (Aoshiba et al., 1997) . The stimulation of cell proliferation and inhibition of apoptosis by fibronectin indicates that this matrix molecule is a mitogen and a survival factor for human bronchial epithelial cells. Fibronectin has been shown to affect cell cycle-related genes such as p21, p27, and cyclin D1, tumor suppressor gene p53, and apoptosis-related genes such as Bcl-2 and Bax in several cell systems (de la Fuente et al., 1999; van Beuningen, 2003, 2004; Orend et al., 2003) . For example, fibronectin altered the survival and intracellular signaling of confluent A549 cell cultures after irradiation by reducing p21 and increasing cyclin D1 and p53 expression (Cordes and van Beuningen, 2004) . Also, fibronectin prolonged G2 arrest in both human lung cancer cells and lung fibroblasts, and this was associated with upregulation of cyclin D1 expression (Cordes and van Beuningen, 2003) . The induction of p53 expression was accompanied by a significant decrease in fibronectin in mouse fibroblasts (Alexandrova et al., 2000) . Also, adhesion of B-cell chronic lymphocytic leukemia cells to fibronectin upregulates the Bcl-2/Bax ratio and this is thought to contribute to the antiapoptotic effect of fibronectin (de la Fuente et al., 1999) . Another gene thought to play important roles in the regulation of cellular growth and differentiation is the proto-oncogene c-myc (Takizawa et al., 1991; Jin et al., 2004) . Adhesion of mammary epithelial cells to fibronectin induces the expression of c-Myc in a dose-dependent fashion (Benaud and Dickson, 2001 ). Here, we found that fibronectin increased the expression of c-Myc in bronchial epithelial cells, suggesting a possible oncogenic role for fibronectin in transformation of these cells.
PTEN is a dual-specificity lipid and protein phosphate and a negative regulator of PI3K-mediated signaling (Sansal and Sellers, 2004) . PTEN directly antagonizes growth factor receptor-and integrin-stimulated signaling, thus promoting cell cycle arrest, decreasing cell migration, and inducing apoptosis (Garl et al., 2004) . Others have shown that PTEN functions as a tumor suppressor by negatively regulating cell interactions with the extracellular matrix (Tamura et al., 1998) . In this study, we found that fibronectin inhibited the expression of PTEN consistent with the role of fibronectin in cell survival processes.
Fibronectin has been demonstrated to stimulate several kinase signaling pathways including PI3-K/Akt (Kijima et al., 2003; Liu et al., 2004) . Phosphatidylinositol 3 kinase is a ubiquitous signaling protein that mediates multiple cellular events such as cell growth and differentiation, and protection against apoptosis, P-ATP and incubated with nuclear extracts (5 mg) from BEAS-2B cells treated with fibronectin (20 mg/ml) for 24 h. For competition assays, a molar excess (Â 100) of consensus NF-kB oligonucleotide was added to the binding reaction. To confirm specificity of binding, we used oligonucleotides containing a mutated NF-kB (Mut NF-kB) that were end-labeled with g 32 P-ATP. An antibody specific for NF-kB subunit p65 was included in the incubation mixture. (b, c) Effects of fibronectin on p65 protein expression. Cellular protein was isolated from BEAS-2B cells that were treated with varying concentrations of fibronectin (b) and for increasing periods of time (c) with fibronectin (20 mg/ml). Afterwards, Western blot analysis was performed using polyclonal antibodies against p65. (d) The role of PI3-K signal in fibronectin-induced p65 protein expression. Cellular protein was isolated from BEAS-2B cells that were treated with Wortmannin (200 nM) for 1 h before exposing the cell to fibronectin (20 mg/ml) for an additional 24 h. Afterwards, Western blot analysis was performed using polyclonal antibodies against p65. Actin served as internal control for normalization purposes. Con, indicates untreated cells. 5 cells/ well) were transfected with p65 siRNA or control siRNA (100 nM each) for 30 h before exposing the cells to fibronectin for an additional 1 h and then subjected to Western Blot analysis for total Akt and phosphor-Akt. Actin was used as internal control for normalization purposes. (c) Effects of p65 siRNA on p21, cyclin D1, PTEN, and c-Myc protein expression. Cellular protein was isolated from BEAS-2B cells transfected with p65 siRNA for 30 h before exposing the cells to fibronectin (20 mg/ml) for an additional 24 h, and then subjected to Western Blot analysis for p21, cyclin D1, PTEN, and c-Myc. (d) Effects of p65 siRNA and Wortmannin on cell proliferation. BEAS-2B cells (0.5 Â 10 5 cells/well) were treated with either solvent control, or transfected with control siRNA or p65 siRNA (100 nM) for 30 h, followed by Wortmannin (100 nM) for 2 h before exposing the cells to 20 mg/ml fibronectin and incubated with 1 mCi/ml [Methyl-3 H]thymidine for an additional 24 h. Afterward, cell numbers were determined. *Indicates significant difference from control (Con). **Indicates significance of combination treatment as compared with fibronectin alone. ***Indicates significance of combination treatment as compared with fibronectin plus p65 siRNA or plus Wortmannin. Con, indicates untreated cell. (e) Schematic representation of the effects of fibronectin on human bronchial epithelial cell growth. This model shows that fibronectin, by binding to its a5b1 integrin receptor, activates the phosphorylation of Akt, a downstream signal of PI3-K; and increases DNA binding of NF-kB and p65 protein expression. This in turn affects the expression of c-Myc, cyclin D1, p21, and PTEN, which results in increased proliferation of human bronchial epithelial cells and reduced apoptosis. The inhibitor of PI3-K, Wortmannin, and small RNA interference of p65 (p65 siRNA) blocked the effects of fibronectin on the expression of those genes and decreased human bronchial epithelial cell growth.
Fibronectin induces human bronchial epithelial cell growth SW Han and J Roman tumorigenesis, and angiogenesis . We found that fibronectin stimulated the phosphorylation of the PI3-K downstream signal Akt, and that the inhibitor of the PI3-K blocked the effects of fibronectin on p21, cyclin D1, PTEN, and c-Myc protein expression indicating an important role for this kinase in controlling gene expression and cell growth regulated by fibronectin. The PI3-K signal pathway has been demonstrated to be involved in the regulation of these genes in different cells (Asano and Yao, 2004; Arcuri et al., 2005; Halder et al., 2005) . In pancreatic cancer cells, the PI3-k/Akt signaling pathway is activated because of aberrant PTEN expression, and it targets the transcription factor c-Myc (Asano and Yao, 2004) . Consistent with our data, the inhibitor of PI3-K, Wortmannin, was shown to block the expression of cell cycle proteins cyclin Ds, p21 (Braun-Dullaeus and Mann, 2001) , and c-Myc (Galmozzi and Casalini, 2004) . Therefore, PI3-K/Akt is one of the key signaling pathways mediating human bronchial epithelial cell survival. Fibronectin had no effects on other kinases such as PKC, protein kinase A (PKA), or mitogenactivated protein kinase (Mek)/Erk (not shown), although these kinases have been shown to mediate fibronectin functions in other cell systems (Tang et al., 2004; Illario et al., 2005; Nasu-Tada et al., 2005) . Many of the biological effects of fibronectin are mediated via a5b1, which belongs to the integrin family of transmembrane receptors involved in cell-matrix interactions, cell-cell adhesion, differentiation, and wound healing (Akiyama et al., 1989; Loeser, 2002) . This receptor has been shown to be expressed at low levels in BEAS-2B, in the human pulmonary epithelial cell line WI-26, and in human primary bronchial epithelial cells as determined by flow cytometry and RT-PCR analysis (Wang et al., 1996; Zhao et al., 2002) . In our system, the effects of fibronectin on protein expression were mediated through a5b1, but not a2b1, suggesting a critical role for a5b1 in mediating the effects of fibronectin in these cells.
Nuclear factor kappaB and its regulators are linked to various signal transduction pathways as well as transcriptional activation events that mediate critical stages of cell proliferation, transformation, and apoptosis (Wu and Kral, 2005) . Fibronectin fragment stimulation of chondrocyte chemokine expression was dependent on NF-kB activity (Pulai and Chen, 2005) . Nuclear factor kappaB-binding activity significantly increased in cells adhered to fibronectin when compared to cells in suspension (Landowski and Olashaw, 2003) . Consistent with this, we found that fibronectin activates NF-kB DNA-binding activity and increases the expression of p65, one of the NF-kB subunits, suggesting that this transcription factor plays a role in mediating the effects of fibronectin. We also found that blockade of the PI3-K signal abrogated the stimulatory effect of fibronectin on p65 expression. In contrast, blockade of NFkB by p65 siRNA did not affect the stimulatory effect of fibronectin on phosphorylation of Akt, suggesting that PI3-K acts upstream of NF-kB. NF-kB promotes cancer cell growth and proliferation by regulating the expression of genes such as c-Myc, cyclin D1 and p21 (Suh and Rabson, 2004) . It also contributes to cell cycle regulation in response to arsenic trioxide in human bronchial epithelial cells (Chen and Lu, 2001) . The efficacy of PTEN in inhibiting cell proliferation and matrix metalloproteinase 9 expression is dependent on NF-kB in vascular smooth muscle cells (Moon et al., 2004) . These observations suggest a key role for NF-kB in regulation of gene expression affected by fibronectin.
We found that blocking the NF-kB signal with p65 siRNA partially inhibited the stimulatory effect of fibronectin in human bronchial epithelial cells. Blockade of NF-kB signaling in MDA-MB-231 cells by the mutant IkappaB decreased in vitro cell proliferation (Gordon and O'Keefe, 2005) . Proliferation and activation of bronchial epithelial cells are also associated with activation of the NF-kB signal (Vignola and Chiappara, 2001 ). Of note, blocking both NF-kB and PI3-K signals completely abolished the stimulatory effect of fibronectin on cell proliferation, suggesting that these signaling pathways are involved in this effect. The PI3-K inhibitors blocked fibronectin-induced cell proliferation and migration in other studies (Kijima et al., 2003; Liu et al., 2004) .
In summary, our findings demonstrate that fibronectin stimulates human bronchial epithelial cell growth through activation of NF-kB, which, in turn, increases c-Myc and cyclin D1 expression, and decreases p21 and PTEN expression via PI3-K/Akt and a5b1 integrindependent signals. Blockade of NF-kB signals completely eliminated the effect of fibronectin on cell growth (Figure 5e ). This suggests that fibronectin might play an important role in regulating cell cycle and tumor suppressor genes in human bronchial epithelial cells thereby influencing their growth.
Materials and methods
Culture and chemicals
The bronchial epithelial cell lines BEAS-2B and 16-HBE were obtained from Drs Shi-Yong Sun and Arlene Stecenko (Emory University, Atlanta, GA, USA). They were maintained in KERATINOCYTE-SFM medium (Cat # 17005, Invitrogen Corporation, Carlsbad, CA, USA) supplemented with human recombinant epidermal growth factor 1-53 (EGF 1-53) and bovine pituitary extract (BPE). Cells were plated into six-well culture plates at an initial seeding density of 5 Â 10 4 cells per well. The plates were incubated in a humidified atmosphere of 5% CO 2 in air at 371C, and experiments were carried out after the cells were passaged by treatment with trypsin, and then reseeded at 80% confluency into culture plates coated with increased concentrations of fibronectin. H]thymidine and Poly (dI-dC) were purchased from Amersham Biosciences (Piscataway, NJ, USA); the TACS Apoptotic DNA Laddering Kits were purchased from R&D System (Minneapolis, MN, USA); the Gel Shift Assay System, Caspase-Glot 3/7 Assay kit, and the 5 0 DNA Terminus Labeling System were obtained from Promega (Madison, WI, USA); and the consensus and its mutated oligonucleotides for NF-kB and polyclonal antibodies specific for c-Myc, p21, cyclin D1, and PKC were obtained from Santa Cruz biotechnology (San Diego, CA, USA Western blot analysis Cells were cultured on plates coated with fibronectin as published (Han et al., 2004) . Afterwards, the cells were harvested and processed as previously described (Han et al., 1996) . Blots were incubated with a5b1 integrin monoclonal antibody (1:1000), polyclonal antibodies raised against c-Myc, p21 (1:1000), PTEN, and cyclin D1 (1:2000) . Afterwards, the blots were incubated with a secondary goat antibody raised against rabbit IgG conjugated to horseradish peroxidase (1:2000). Protein bands were quantified by densitometric scanning using a BioRad GS-800 calibrated densitometer. In controls, the antibodies were omitted or replaced by control rabbit IgG.
P65 small interfering RNA treatment
The p65 siRNA duplexes (siRNA ID#: 216912, Cat No. 16708) and negative control siRNA (Cat No. 4611) were purchased from Ambion (Austin, TX, USA). For the transfection procedure, cells were grown to 60% confluence and p65 siRNA or control siRNA were transfected using the Lipofectaminet 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Briefly, Lipofectaminet 2000 reagent was incubated with serum-free medium for 10 min. Subsequently, a mixture of respective siRNA was added. After incubation for 15 min at room temperature, the mixture was diluted with medium and added to each well. The final concentration of siRNA in each well was 100 nM. After culturing for 30 h, cells were washed, resuspended in new culture media, and treated with or without fibronectin and with 1 mCi/ml [methyl- 
[Methyl-
3 H]thymidine incorporation assay The procedure was performed as previously described (Han et al., 2004) . Briefly, BEAS-2B cells were transfected with p65 siRNA for up to 30 h followed by incubation with Wortmannin for 2 h, and 1 mCi/ml [methyl-3 H]thymidine (Amersham, specific activity 250 Ci/mmol) in the presence or absence of coated fibronectin for an additional 24 h. The medium was removed and the attached cells were washed with 1 Â PBS. Afterwards, the attached cells were treated with ice-cold 6% trichloroacetic acid (TCA) at 41C for 20 min and washed once with 6% TCA. The cells were then solubilized with 0.1 N NaOH and counted in a liquid scintillation counter in 4 ml of scintillation fluid.
Real-time RT-PCR
The procedure was performed as previously described (Han et al., 2004 (Tell et al., 2004; Dai et al., 2005; Han et al., 2005) . The final results, which were expressed as n-fold differences in target gene expression relative to that of the GAPDH gene, were calculated as described previously (Han et al., 2004 (Han et al., , 2005 . The total RNA preparation was identical to that described for RT-PCR (Han et al., 2004) . Experiments were performed in triplicate for each data point. For all experiments, controls without templates were included.
Detection of DNA fragmentation
Internucleosomal degradation of genomic DNA because of activation of endogenous endonuclease is one feature of apoptosis. The release of oligonucleosome-associated DNA fragments in this process results in a DNA ladder when analysed by agarose gel electrophoresis. We evaluated apoptosis by detecting internucleosomal DNA fragmentation and displaying DNA laddering using the TACS Apoptotic DNA Laddering Kit (R&D Systems) as described before (Han et al., 2005) . Cells were seeded in serum-free RPMI-1640 medium in the presence or absence of coated fibronectin (20 mg/ml) for 48 h. DNA isolation and detection were performed following the protocol provided by the product supplier. After running it in a 1.5% TreviGel 500 gel (% [w/v]) in 1 Â TAE, DNA was visualized with ethidium bromide staining under a UV transilluminator and photographed.
Measurement of caspase 3 and caspase 7 activities
Caspases are proteolytic enzymes that become activated during the process of apoptosis. The detection of the activity of executioner caspases such as caspase-3 and -7 is a reliable indicator of apoptosis in cells. BEAS-2B cells were cultured in 96-well uncoated plates or plates coated with fibronectin for 48 h. Afterwards, caspase-3/7 activities were evaluated using the Caspase-Glot 3/7 Assay kit, which is based on the cleavage of a profluorescent EDVD peptide-rhodamine 110 substrate, according to the manufacturer's instructions (Promega, Madison, WI, USA).
Electrophoretic mobility shift assay Nuclear protein extracts from BEAS-2B cells cultured on fibronectin-coated plates were prepared for electrophoretic mobility shift assay (EMSA) as described before (Dignam et al., 1983) . The protein content of the nuclear extract was determined using the Bradford protein assay kit (BioRad). Electrophoretic mobility shift assay experiments were performed as described before (Han and Sidell, 2003) . The double-stranded oligonucleotides for NF-kB were as follows: wild-type NF-kB (5 0 -AGT TGA GGG GAC TTT CCC AGG C-3 0 ) and mutant NF-kB (5 0 -AGT TGA GGG GAC TTT CCC AGG C-3 0 ). Nuclear proteins (5 mg) from control and treated cells were incubated with 32 P-labeled oligonucleotide probe in the presence or absence of antibody against p65 protein (2 mg/ml). For cold competition, a 100-fold excess of the respective unlabeled consensus oligonucleotide was added before adding probe. The same amount of mutated oligonucleotides or 100-fold excess of mutated oligonucleotides was used as another control.
Statistical analysis
All experiments were repeated a minimum of three times. All data were expressed as means7s.d. The data presented in some figures are from a representative experiment, which was qualitatively similar in the replicate experiments. Statistical significance was determined with Student's t-test (two-tailed) comparison between two groups of data set. Asterisks shown in the figures indicate significant differences of experimental groups in comparison with the corresponding control condition (Po0.05, see figure legends).
